Come up with a name for your new list and we'll add to it:
BioMARC raised a round of funding on February 28, 2017. Investors include
U.S. Department of Defense.
BioMARC is developing a drug to protect U.S. soldiers from a mosquito-borne pathogen that can cause severe illness and death.…